Last checked at 30 Nov 2023 10:00
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")
30/11/2023
Valereum Plc
("Valereum" or the "Company")
New Board Appointment
Valereum Plc (AQUIS: VLRM), the Gibraltar technology group, is today announcing the following new board appointment:
Karl Moss will be joining the Company as Chief Financial Officer (CFO). Karl brings 30 years' experience across financial planning, compliance and corporate finance, including 20 years' Board experience as CFO, delivering sector leading growth leading to significant realisations in shareholder value in the SAL Group and the i2 Group.
The following information is provided for the purpose of Rule 4.9 of the AQSE Growth Market Access Rulebook for Karl Moss.
Current directorships and/or partnerships:? | Former directorships and/or partnerships (within the last five years):?
|
I2 Analytical Limited Scientific Analysis Instruments Limited Gatenet Technology Limited Mycotoxin Laboratory UK Ltd I2 Fast Limited Hallco (479) Limited | None |
Karl was Financial Director of REC CHSS Training Limited and its dormant parent holding company Corporate Health & Safety Services Limited. Karl resigned from the company on 19th July 2013. The parent company went into administration on 11th March 2014 following a failed MBO by the management team in preparation for a divestment of the wider group company.
There is no further information to be disclosed pursuant to Rule 4.9 of the AQSE Growth Market Access Rulebook.£
The Directors of the Company accept responsibility for the contents of this announcement.
For more information, please visit the Company's website at Valereum.gi
Enquiries:
Valereum Plc
James Formolli, Chairman
Tel: +971 4584 6284
AQSE Corporate Adviser
First Sentinel Corporate Finance
Brian Stockbridge
Tel: +44 20 3855 5551